Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Von Hippel-Lindau disease is a hereditary syndrome associated with various benign and malignant tumors, including hemangioblastomas. A 42-year-old man with a history of Von Hippel-Lindau disease underwent surgery for pancreatic neuroendocrine tumor and renal clear cell carcinoma and was recommended to undergo Al18F-NOTA-octreotide and 18F-FDG PETCT examination to assess potential metastases. 18F-FDG PET/CT showed low uptake in the right cerebellum, which demonstrated increased Al18F-NOTA-octreotide activity. Cerebellar mass resection surgery was performed. Pathological result was consistent with hemangioblastoma. This case report indicates the significant role of Al18F-NOTA-octreotide in the diagnosis of hemangioblastoma. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Guozhu Hou, Xin Cheng, Yihebali Chi, Xuejuan Wang, Rong Zheng. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease. Clinical nuclear medicine. 2024 Mar 01;49(3):289-291

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38306383

View Full Text